A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In Pancreatic Islet Auto-Transplantation.
Posted Date: Aug 12, 2017
- Investigator: Syed Ahmad
- Type of Study: Drug
The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.
To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have Pancreas Removed And Have A Pancreatic Islet Auto-Transplant
Pancreatic Islet Auto-Transplantation, Chronic, Rep0112, Pancreatitis, Null
For More Information:
Uc Cancer Institute